A PASSION FORSUPPORTINGPATIENTS
Impactful Voices
Come celebrate the extraordinary
Advocacy is the common thread
we thrive on
Our guiding principles
WE LISTEN to and integrate patient communities’ needs and insights, to ensure they are at the core of all we do
WE CULTIVATE enduring partnerships and collaborations through trust and transparency while valuing the autonomy of the patient organizations
WE PROVIDE support to patient organizations to advance shared goals, improve patient outcomes, increase disease awareness, and cultivate patient-focused policies
WE VALUE patient communities and organizations while adhering to all rules governing patient privacy and compliant collaborations
WE ADVOCATE for access to resources and all approved treatment options
WE UNDERSTAND that partnering with or providing financial support to patient communities is not contingent on a promotion or endorsement of a specific medicine or treatment
Grants and sponsorships:
Collaborating with the communities we serve
We build genuine, enduring relationships based on trust and transparency with members of the rare disease community—including those who belong to the hereditary angioedema and complement-mediated disease communities—and all who support them. Through collaboration and listening, we meet patient communities where they are and foster empowerment through educational awareness and support initiatives. We offer a range of opportunities to provide financial support to these communities, from educational grants and sponsorships to charitable donations.
Request a grant, sponsorship, or donation >>
Your right to
privacy
Clinical research is critical for the development of medicines for rare disease. Just as we at BioCryst recognize the importance of sharing clinical trial data to advance our research, we also hold patient privacy to the highest standards. Find out more.
Clinical trials and data transparency >>
We are fortunate to work with some
extraordinary patient advocacy organizations
Have questions about our commitment to rare disease patient communities or how we work with patient advocates? Contact us >>